Group One Trading
JUNO

Group One Trading’s Juno Therapeutics, Inc. JUNO Stock Holding History

Group One Trading’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-79,579
Closed -$2.71M – 5462
2017
Q2 		$2.38M Sell
79,579
-12,422
-14% -$307K 0.02% 853
2017
Q1 		$2.04M Sell
92,001
-62,518
-40% -$1.34M 0.02% 851
2016
Q4 		$2.91M Buy
154,519
+123,686
+401% +$3.03M 0.03% 716
2016
Q3 		$925K Sell
30,833
-26,668
-46% -$830K 0.01% 1335
2016
Q2 		$2.21M Buy
57,501
+33,369
+138% +$1.39M 0.03% 772
2016
Q1 		$919K Buy
24,132
+7,770
+47% +$271K 0.01% 1237
2015
Q4 		$719K Buy
+16,362
New +$811K 0.01% 1548
2015
Q3 		– Sell
-49,031
Closed -$2.15M – 5480
2015
Q2 		$2.62M Buy
49,031
+24,896
+103% +$1.32M 0.04% 594
2015
Q1 		$1.46M Buy
+24,135
New +$1.17M 0.02% 812

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Group One Trading's JUNO Position: Q3 2017 in Review

Group One Trading sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2017, closing a stake of 79,579 shares — an estimated $2.71M sold.

Group One Trading first reported a position in JUNO in Q1 2015 and held it in 9 quarters. The position peaked at $2.91M in Q4 2016. 210 funds tracked by Wall St. Rank hold JUNO as of Q3 2017.

  • Group One Trading reported no remaining Juno Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Group One Trading sold 79,579 Juno Therapeutics, Inc. shares in Q3 2017, an estimated $2.71M.
  • Group One Trading first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 9 quarters.
  • Group One Trading's Juno Therapeutics, Inc. position peaked at $2.91M in Q4 2016.
  • 210 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2017.

Based on Group One Trading's 13F filing for Q3 2017, filed 15 Nov 2017.